Biomanufacturing in Space to Be Key Topic at ISSCR 2026
Scientists from the Cedars-SinaiBoard of Governors Regenerative Medicine Institute, including investigators from theCedars-Sinai Biomanufacturing Center, say they will share groundbreaking discoveries and discuss new frontiers in research atISSCR 2026. The annual meeting of the International Society for Stem Cell Research will take in Montreal from July 8–11.
TheCedars-Sinai Center for Space Medicine Researchhas taken a special interest in biomanufacturing in space. It studies how microgravity aboard the International Space Station and other space platforms can be used to manufacture higher-quality biomedical products.
Researchers investigate the production of stem cells, organoids, engineered tissues, exosomes, and biopharmaceuticals, taking advantage of the reduced effects of gravity on cell growth and three-dimensional tissue formation.
The center collaborates with NASA, commercial space companies, and biotechnology partners to determine whether space-based manufacturing can yield therapies with improved quality, consistency, and function. Its long-term goal is to translate discoveries made in space into scalable manufacturing methods that advance regenerative medicine, drug development, and personalized healthcare on Earth.
At the upcoming ISSCR 2026 meeting, Arun Sharma, PhD, director of the Center for Space Medicine Research, will participate in a session co-sponsored by Cedars-Sinai on regenerative medicine in low Earth orbit. The focus of Sharma’s talk is accelerating development of organoid-based disease modeling and stem cell therapies due to increased access to microgravity, as well as in-space biomanufacturing.
Avinash Srivastava, PhD, a biomedical scientist in the Cedars-Sinai Biomanufacturing Center, is presenting information on the center’s proprietary integrated induced pluripotent stem cell biomanufacturing platform. The platform integrates standardized manufacturing with advanced bioprocessing to facilitate the scalable production of high-quality engineered cell therapies.
Dhruv Sareen, PhD, associate professor of Biomedical Sciences and founding director of the Cedars-Sinai Biomanufacturing Center, is presenting research on the integration of anin situseed plating system into the center’s manufacturing workflow to streamline production of complex induced pluripotent stem cell lines for clinical-grade and research use.
InsightsBiomanufacturingBiomedical researchCell therapyInduced pluripotent stem cellsOrganoidsRegenerative medicinePrevious article
New sa‑mRNA and LNP Platform to Support Korea’s Hantavirus Vaccine InitiativeNext article
A New Development Playbook for PROTACsAlso of Interest
Bone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and BehaviorManus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE ProgramSmarter Cell Culture Starts with Better MediaCAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research CollaborationRevvity Signs Agreement to Acquire Human Cell DesignTop 10 Contract Development and Manufacturing Organizations 2026Related Media
AACR 2026 Video Update: Cancer Research Edges Toward an AI-Driven EraOmics in Orlando Day 2: A Video Report from AGBTSmart Vector Design for Improved Cell and Gene TherapiesFrom Functional Genomics to Cell Therapy: The Role of CRISPR-Based Gene EditingAACR 2025: A Video Update from ChicagoPrecision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene TherapiesTop 5ResourcesRecommended For YouPodcast
Touching Base
Touching Base is the dynamic podcast series from the editors ofGEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.Start listening today!
Stay up to date with the lasted episodes of Touching Base bysubscribing to theGENPodcast Newsletter
